Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Proceedings from the Albert Charitable Trust Inaugural Workshop on white matter and cognition in aging.

Sorond FA, Whitehead S, Arai K, Arnold D, Carmichael ST, De Carli C, Duering M, Fornage M, Flores-Obando RE, Graff-Radford J, Hamel E, Hess DC, Ihara M, Jensen MK, Markus HS, Montagne A, Rosenberg G, Shih AY, Smith EE, Thiel A, Tse KH, Wilcock D, Barone F.

Geroscience. 2019 Dec 6. doi: 10.1007/s11357-019-00141-8. [Epub ahead of print] Review.

PMID:
31811528
2.

Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO.

Slifstein M, Abi-Dargham A, Girgis RR, Suckow RF, Cooper TB, Divgi CR, Sokoloff P, Leriche L, Carberry P, Oya S, Joseph SK, Guiraud M, Montagne A, Brunner V, Gaudoux F, Tonner F.

Psychopharmacology (Berl). 2019 Nov 26. doi: 10.1007/s00213-019-05387-w. [Epub ahead of print]

PMID:
31773210
3.

Temporal features of sitting, standing and stepping changes in a cluster-randomised controlled trial of a workplace sitting-reduction intervention.

Stephens SK, Winkler EAH, Eakin EG, Clark BK, Owen N, Moodie M, La Montagne AD, Dunstan DW, Healy GN.

Int J Behav Nutr Phys Act. 2019 Nov 21;16(1):111. doi: 10.1186/s12966-019-0879-1.

4.

Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss.

Nikolakopoulou AM, Montagne A, Kisler K, Dai Z, Wang Y, Huuskonen MT, Sagare AP, Lazic D, Sweeney MD, Kong P, Wang M, Owens NC, Lawson EJ, Xie X, Zhao Z, Zlokovic BV.

Nat Neurosci. 2019 Jul;22(7):1089-1098. doi: 10.1038/s41593-019-0434-z. Epub 2019 Jun 24.

PMID:
31235908
5.

Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia.

Bitter I, Lieberman JA, Gaudoux F, Sokoloff P, Groc M, Chavda R, Delsol C, Barthe L, Brunner V, Fabre C, Fagard M, Montagne A, Tonner F.

Neuropsychopharmacology. 2019 Oct;44(11):1917-1924. doi: 10.1038/s41386-019-0355-2. Epub 2019 Mar 1.

PMID:
30822774
6.

Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.

Nation DA, Sweeney MD, Montagne A, Sagare AP, D'Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Chui HC, Law M, Toga AW, Zlokovic BV.

Nat Med. 2019 Feb;25(2):270-276. doi: 10.1038/s41591-018-0297-y. Epub 2019 Jan 14.

7.

Vascular dysfunction-The disregarded partner of Alzheimer's disease.

Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ, Jacobs RE, Doubal FN, Ramirez J, Black SE, Nedergaard M, Benveniste H, Dichgans M, Iadecola C, Love S, Bath PM, Markus HS, Salman RA, Allan SM, Quinn TJ, Kalaria RN, Werring DJ, Carare RO, Touyz RM, Williams SCR, Moskowitz MA, Katusic ZS, Lutz SE, Lazarov O, Minshall RD, Rehman J, Davis TP, Wellington CL, González HM, Yuan C, Lockhart SN, Hughes TM, Chen CLH, Sachdev P, O'Brien JT, Skoog I, Pantoni L, Gustafson DR, Biessels GJ, Wallin A, Smith EE, Mok V, Wong A, Passmore P, Barkof F, Muller M, Breteler MMB, Román GC, Hamel E, Seshadri S, Gottesman RF, van Buchem MA, Arvanitakis Z, Schneider JA, Drewes LR, Hachinski V, Finch CE, Toga AW, Wardlaw JM, Zlokovic BV.

Alzheimers Dement. 2019 Jan;15(1):158-167. doi: 10.1016/j.jalz.2018.07.222.

8.

Blood-Brain Barrier: From Physiology to Disease and Back.

Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV.

Physiol Rev. 2019 Jan 1;99(1):21-78. doi: 10.1152/physrev.00050.2017. Review.

PMID:
30280653
9.

Dual-specificity phosphatase 6 deletion protects the colonic epithelium against inflammation and promotes both proliferation and tumorigenesis.

Beaudry K, Langlois MJ, Montagne A, Cagnol S, Carrier JC, Rivard N.

J Cell Physiol. 2019 May;234(5):6731-6745. doi: 10.1002/jcp.27420. Epub 2018 Oct 1.

10.

The role of brain vasculature in neurodegenerative disorders.

Sweeney MD, Kisler K, Montagne A, Toga AW, Zlokovic BV.

Nat Neurosci. 2018 Oct;21(10):1318-1331. doi: 10.1038/s41593-018-0234-x. Epub 2018 Sep 24. Review.

11.

Permeability imaging as a predictor of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Russin JJ, Montagne A, D'Amore F, He S, Shiroishi MS, Rennert RC, Depetris J, Zlokovic BV, Mack WJ.

J Cereb Blood Flow Metab. 2018 Jun;38(6):973-979. doi: 10.1177/0271678X18768670. Epub 2018 Apr 3.

12.

Pericyte degeneration causes white matter dysfunction in the mouse central nervous system.

Montagne A, Nikolakopoulou AM, Zhao Z, Sagare AP, Si G, Lazic D, Barnes SR, Daianu M, Ramanathan A, Go A, Lawson EJ, Wang Y, Mack WJ, Thompson PM, Schneider JA, Varkey J, Langen R, Mullins E, Jacobs RE, Zlokovic BV.

Nat Med. 2018 Mar;24(3):326-337. doi: 10.1038/nm.4482. Epub 2018 Feb 5.

13.

Alzheimer's disease: A matter of blood-brain barrier dysfunction?

Montagne A, Zhao Z, Zlokovic BV.

J Exp Med. 2017 Nov 6;214(11):3151-3169. doi: 10.1084/jem.20171406. Epub 2017 Oct 23. Review.

14.

Pain relief of sore throat with a new anti-inflammatory throat lozenge, ibuprofen 25 mg: A randomised, double-blind, placebo-controlled, international phase III study.

Bouroubi A, Donazzolo Y, Donath F, Eccles R, Russo M, Harambillet N, Gautier S, Montagne A.

Int J Clin Pract. 2017 Sep;71(9). doi: 10.1111/ijcp.12961. Epub 2017 Sep 4.

PMID:
28869722
15.

Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease.

Kisler K, Nelson AR, Montagne A, Zlokovic BV.

Nat Rev Neurosci. 2017 Jul;18(7):419-434. doi: 10.1038/nrn.2017.48. Epub 2017 May 18. Review.

16.

Regional early and progressive loss of brain pericytes but not vascular smooth muscle cells in adult mice with disrupted platelet-derived growth factor receptor-β signaling.

Nikolakopoulou AM, Zhao Z, Montagne A, Zlokovic BV.

PLoS One. 2017 Apr 25;12(4):e0176225. doi: 10.1371/journal.pone.0176225. eCollection 2017.

17.

Biocompatibility of sol-gel hydroxyapatite-titania composite and bilayer coatings.

Sidane D, Rammal H, Beljebbar A, Gangloff SC, Chicot D, Velard F, Khireddine H, Montagne A, Kerdjoudj H.

Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:650-658. doi: 10.1016/j.msec.2016.11.129. Epub 2016 Dec 5.

PMID:
28024634
18.

Safety of Oral Propranolol for the Treatment of Infantile Hemangioma: A Systematic Review.

Léaute-Labrèze C, Boccara O, Degrugillier-Chopinet C, Mazereeuw-Hautier J, Prey S, Lebbé G, Gautier S, Ortis V, Lafon M, Montagne A, Delarue A, Voisard JJ.

Pediatrics. 2016 Oct;138(4). pii: e20160353. Review.

19.

Brain imaging of neurovascular dysfunction in Alzheimer's disease.

Montagne A, Nation DA, Pa J, Sweeney MD, Toga AW, Zlokovic BV.

Acta Neuropathol. 2016 May;131(5):687-707. doi: 10.1007/s00401-016-1570-0. Epub 2016 Apr 1. Review.

20.

Blood-Brain Barrier Permeability and Gadolinium: Benefits and Potential Pitfalls in Research.

Montagne A, Toga AW, Zlokovic BV.

JAMA Neurol. 2016 Jan;73(1):13-4. doi: 10.1001/jamaneurol.2015.2960. Review. No abstract available.

21.

Tissue Plasminogen Activator Expression Is Restricted to Subsets of Excitatory Pyramidal Glutamatergic Neurons.

Louessard M, Lacroix A, Martineau M, Mondielli G, Montagne A, Lesept F, Lambolez B, Cauli B, Mothet JP, Vivien D, Maubert E.

Mol Neurobiol. 2016 Sep;53(7):5000-12. doi: 10.1007/s12035-015-9432-7. Epub 2015 Sep 16.

PMID:
26377106
22.

Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI.

Barnes SR, Ng TS, Montagne A, Law M, Zlokovic BV, Jacobs RE.

Magn Reson Med. 2016 May;75(5):1967-77. doi: 10.1002/mrm.25793. Epub 2015 Jun 16.

23.

ROCKETSHIP: a flexible and modular software tool for the planning, processing and analysis of dynamic MRI studies.

Barnes SR, Ng TS, Santa-Maria N, Montagne A, Zlokovic BV, Jacobs RE.

BMC Med Imaging. 2015 Jun 16;15:19. doi: 10.1186/s12880-015-0062-3.

24.

Impact of alcohol consumption on the outcome of ischemic stroke and thrombolysis: role of the hepatic clearance of tissue-type plasminogen activator.

Lemarchand E, Gauberti M, Martinez de Lizarrondo S, Villain H, Repessé Y, Montagne A, Vivien D, Ali C, Rubio M.

Stroke. 2015 Jun;46(6):1641-50. doi: 10.1161/STROKEAHA.114.007143. Epub 2015 Apr 28.

PMID:
25922513
25.

7T Multi-shell Hybrid Diffusion Imaging (HYDI) for Mapping Brain Connectivity in Mice.

Daianu M, Jahanshad N, Villalon-Reina JE, Prasad G, Jacobs RE, Barnes S, Zlokovic BV, Montagne A, Thompson PM.

Proc SPIE Int Soc Opt Eng. 2015 Mar 20;9413. pii: 941309.

26.

Vascular plasticity and cognition during normal aging and dementia.

Montagne A, Pa J, Zlokovic BV.

JAMA Neurol. 2015 May;72(5):495-6. doi: 10.1001/jamaneurol.2014.4636. No abstract available.

27.

Blood-brain barrier breakdown in the aging human hippocampus.

Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, Toga AW, Jacobs RE, Liu CY, Amezcua L, Harrington MG, Chui HC, Law M, Zlokovic BV.

Neuron. 2015 Jan 21;85(2):296-302. doi: 10.1016/j.neuron.2014.12.032.

28.

Molecular magnetic resonance imaging of brain-immune interactions.

Gauberti M, Montagne A, Quenault A, Vivien D.

Front Cell Neurosci. 2014 Nov 27;8:389. doi: 10.3389/fncel.2014.00389. eCollection 2014. Review.

29.

Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis.

Gaberel T, Montagne A, Lesept F, Gauberti M, Lemarchand E, Orset C, Goulay R, Bertrand T, Emery E, Vivien D.

Neuropharmacology. 2014 Oct;85:158-65. doi: 10.1016/j.neuropharm.2014.05.001. Epub 2014 May 15.

PMID:
24846802
30.

GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice.

Le Behot A, Gauberti M, Martinez De Lizarrondo S, Montagne A, Lemarchand E, Repesse Y, Guillou S, Denis CV, Maubert E, Orset C, Vivien D.

Blood. 2014 May 22;123(21):3354-63. doi: 10.1182/blood-2013-12-543074. Epub 2014 Feb 19.

PMID:
24553181
31.

Intracerebral hematomas disappear on T2*-weighted images during normobaric oxygen therapy.

Gaberel T, Gakuba C, Hebert M, Montagne A, Agin V, Rubio M, Emery E, Vivien D, Gauberti M.

Stroke. 2013 Dec;44(12):3482-9. doi: 10.1161/STROKEAHA.113.002045. Epub 2013 Oct 8.

PMID:
24105700
32.

Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.

Matthey A, Cedraschi C, Piguet V, Besson M, Chabert J, Daali Y, Courvoisier D, Montagne A, Dayer P, Desmeules JA.

Pain Physician. 2013 Sep-Oct;16(5):E553-62.

33.

Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes.

Gauberti M, Montagne A, Marcos-Contreras OA, Le Béhot A, Maubert E, Vivien D.

Stroke. 2013 Jul;44(7):1988-96. doi: 10.1161/STROKEAHA.111.000544. Epub 2013 Jun 6.

PMID:
23743972
34.

Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome.

Gaberel T, Macrez R, Gauberti M, Montagne A, Hebert M, Petersen KU, Touze E, Agin V, Emery E, Ali C, Vivien D.

Neuropharmacology. 2013 Apr;67:267-71. doi: 10.1016/j.neuropharm.2012.11.023. Epub 2012 Dec 3.

PMID:
23219658
35.

Bcl3 selectively promotes metastasis of ERBB2-driven mammary tumors.

Wakefield A, Soukupova J, Montagne A, Ranger J, French R, Muller WJ, Clarkson RW.

Cancer Res. 2013 Jan 15;73(2):745-55. doi: 10.1158/0008-5472.CAN-12-1321. Epub 2012 Nov 13.

36.

Memantine improves safety of thrombolysis for stroke.

Montagne A, Hébert M, Jullienne A, Lesept F, Le Béhot A, Louessard M, Gauberti M, Orset C, Ali C, Agin V, Maubert E, Vivien D.

Stroke. 2012 Oct;43(10):2774-81. Epub 2012 Aug 9.

PMID:
22879098
37.

Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders.

Montagne A, Gauberti M, Macrez R, Jullienne A, Briens A, Raynaud JS, Louin G, Buisson A, Haelewyn B, Docagne F, Defer G, Vivien D, Maubert E.

Neuroimage. 2012 Nov 1;63(2):760-70. doi: 10.1016/j.neuroimage.2012.07.018. Epub 2012 Jul 17.

PMID:
22813950
38.

Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity.

Parcq J, Bertrand T, Montagne A, Baron AF, Macrez R, Billard JM, Briens A, Hommet Y, Wu J, Yepes M, Lijnen HR, Dutar P, Anglés-Cano E, Vivien D.

Cell Death Differ. 2012 Dec;19(12):1983-91. doi: 10.1038/cdd.2012.86. Epub 2012 Jun 29.

39.

Glutamate controls tPA recycling by astrocytes, which in turn influences glutamatergic signals.

Cassé F, Bardou I, Danglot L, Briens A, Montagne A, Parcq J, Alahari A, Galli T, Vivien D, Docagne F.

J Neurosci. 2012 Apr 11;32(15):5186-99. doi: 10.1523/JNEUROSCI.5296-11.2012.

40.

Selective inhibition of GluN2D-containing N-methyl-D-aspartate receptors prevents tissue plasminogen activator-promoted neurotoxicity both in vitro and in vivo.

Jullienne A, Montagne A, Orset C, Lesept F, Jane DE, Monaghan DT, Maubert E, Vivien D, Ali C.

Mol Neurodegener. 2011 Oct 5;6:68. doi: 10.1186/1750-1326-6-68.

41.

Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.

Vivien D, Gauberti M, Montagne A, Defer G, Touzé E.

J Cereb Blood Flow Metab. 2011 Nov;31(11):2119-34. doi: 10.1038/jcbfm.2011.127. Epub 2011 Aug 31. Review.

42.

Tissue plasminogen activator prevents white matter damage following stroke.

Correa F, Gauberti M, Parcq J, Macrez R, Hommet Y, Obiang P, Hernangómez M, Montagne A, Liot G, Guaza C, Maubert E, Ali C, Vivien D, Docagne F.

J Exp Med. 2011 Jun 6;208(6):1229-42. doi: 10.1084/jem.20101880. Epub 2011 May 16.

43.

Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.

Branco JC, Cherin P, Montagne A, Bouroubi A; Multinational Coordinator Study Group.

J Rheumatol. 2011 Jul;38(7):1403-12. doi: 10.3899/jrheum.101025. Epub 2011 Apr 1.

PMID:
21459941
45.
46.

NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity.

Baron A, Montagne A, Cassé F, Launay S, Maubert E, Ali C, Vivien D.

Cell Death Differ. 2010 May;17(5):860-71. doi: 10.1038/cdd.2009.172. Epub 2009 Nov 13.

47.

[A survey of pain prevalence at Albert-Chenevier Hospital. Comparison of patient, caregivers and physician assessments].

Jeanfaivre V, Diviné C, Akalin MN, Anacharsis F, Montagne A, Le Parco JC.

Ann Med Interne (Paris). 2003 Dec;154(8):499-508. French.

PMID:
15037825
48.

Cytokine gene expression in lymph node and spleen of sheep in response to Salmonella infection by two serotypes displaying different host specificity.

Montagne A, Menanteau P, Boivin R, Bernard S, Lantier F, Lalmanach AC.

Vet Immunol Immunopathol. 2001 Oct;82(3-4):257-72.

PMID:
11587739
49.

[Belated diagnosis of medullar compression in a case of post-polio syndrome].

Boulay C, Hamonet C, Galaup N, Djindjian M, Montagne A, Vivant R.

Ann Readapt Med Phys. 2001 Mar;44(3):150-2. French.

PMID:
11587662
50.

Effect of the mouse Nramp1 genotype on the expression of IFN-gamma gene in early response to Salmonella infection.

Lalmanach AC, Montagne A, Menanteau P, Lantier F.

Microbes Infect. 2001 Jul;3(8):639-44.

PMID:
11445450

Supplemental Content

Loading ...
Support Center